{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T06:14:12Z","timestamp":1776406452125,"version":"3.51.2"},"reference-count":48,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,10]],"date-time":"2021-07-10T00:00:00Z","timestamp":1625875200000},"content-version":"am","delay-in-days":343,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer\/Radioth\u00e9rapie"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.canrad.2020.04.009","type":"journal-article","created":{"date-parts":[[2020,6,10]],"date-time":"2020-06-10T07:53:32Z","timestamp":1591775612000},"page":"379-387","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Radiological assessment after stereotactic body radiation of lung tumours"],"prefix":"10.1016","volume":"24","author":[{"given":"G.","family":"Chassagnon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Martini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Giraud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.-P.","family":"Revel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.canrad.2020.04.009_bib0245","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.clon.2009.12.003","article-title":"Stereotactic body radiotherapy: a review","volume":"22","author":"Martin","year":"2010","journal-title":"Clin Oncol"},{"key":"10.1016\/j.canrad.2020.04.009_bib0250","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/S1470-2045(12)70242-5","article-title":"Patterns of disease recurrence after stereotactic ablative radiotherapy for early stage non-small-cell lung cancer: a retrospective analysis","volume":"13","author":"Senthi","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.canrad.2020.04.009_bib0255","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1001\/jama.2010.261","article-title":"Stereotactic body radiation therapy for inoperable early stage lung cancer","volume":"303","author":"Timmerman","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.canrad.2020.04.009_bib0260","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/S1470-2045(15)70168-3","article-title":"Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials","volume":"16","author":"Chang","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.canrad.2020.04.009_bib0265","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s13014-017-0773-4","article-title":"Lung metastases treated with stereotactic body radiotherapy: the RSSearch\u00ae patient Registry's experience","volume":"12","author":"Ricco","year":"2017","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.canrad.2020.04.009_bib0270","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1080\/02841860600908954","article-title":"Stereotactic body radiation therapy (SBRT) for lung metastases","volume":"45","author":"Okunieff","year":"2006","journal-title":"Acta Oncol"},{"key":"10.1016\/j.canrad.2020.04.009_bib0275","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1634\/theoncologist.2012-0092","article-title":"Review and uses of stereotactic body radiation therapy for oligometastases","volume":"17","author":"Alongi","year":"2012","journal-title":"Oncologist"},{"key":"10.1016\/j.canrad.2020.04.009_bib0280","doi-asserted-by":"crossref","first-page":"3446","DOI":"10.12659\/MSM.902353","article-title":"The cellular and molecular mechanism of radiation-induced lung injury","volume":"23","author":"Huang","year":"2017","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.canrad.2020.04.009_bib0285","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.diii.2016.06.019","article-title":"Imaging after radiation therapy of thoracic tumors","volume":"97","author":"Ghaye","year":"2016","journal-title":"Diagn Interv Imaging"},{"key":"10.1016\/j.canrad.2020.04.009_bib0290","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/j.ijrobp.2016.03.024","article-title":"Simple factors associated with radiation-induced lung toxicity after stereotactic body radiation therapy of the thorax: a pooled analysis of 88 studies","volume":"95","author":"Zhao","year":"2016","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.canrad.2020.04.009_bib0295","doi-asserted-by":"crossref","first-page":"20160508","DOI":"10.1259\/bjr.20160508","article-title":"Predicting risk factors for radiation pneumonitis after stereotactic body radiation therapy for primary or metastatic lung tumours","volume":"90","author":"Okubo","year":"2017","journal-title":"Br J Radiol"},{"key":"10.1016\/j.canrad.2020.04.009_bib0300","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1097\/JTO.0b013e318219aac5","article-title":"Radiological changes after stereotactic radiotherapy for stage I lung cancer","volume":"6","author":"Dahele","year":"2011","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.canrad.2020.04.009_bib0305","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1148\/rg.2018170155","article-title":"Stereotactic body radiation therapy for early-stage non\u2013small cell lung cancer: a primer for radiologists","volume":"38","author":"Febbo","year":"2018","journal-title":"RadioGraphics"},{"key":"10.1016\/j.canrad.2020.04.009_bib0310","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.radonc.2011.12.018","article-title":"Radiographic changes after lung stereotactic ablative radiotherapy (SABR)\u2013Can we distinguish recurrence from fibrosis? A systematic review of the literature","volume":"102","author":"Huang","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2020.04.009_bib0315","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.ijrobp.2010.02.032","article-title":"Radiological and Clinical pneumonitis after stereotactic lung radiotherapy: a matched analysis of three-dimensional conformal and volumetric-modulated arc therapy techniques","volume":"80","author":"Palma","year":"2011","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.canrad.2020.04.009_bib0320","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.2214\/ajr.178.6.1781383","article-title":"Radiation injury of the lung after three-dimensional conformal radiation therapy","volume":"178","author":"Koenig","year":"2002","journal-title":"Am J Roentgenol"},{"key":"10.1016\/j.canrad.2020.04.009_bib0325","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.ctrv.2008.06.001","article-title":"Can stereotactic fractionated radiation therapy become the standard of care for early stage non-small cell lung carcinoma","volume":"34","author":"Nguyen","year":"2008","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.canrad.2020.04.009_bib0330","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/JTO.0b013e31827ce361","article-title":"Patterns of failure after stereotactic body radiation therapy or lobar resection for clinical stage I non\u2013small-cell lung cancer","volume":"8","author":"Robinson","year":"2013","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.canrad.2020.04.009_bib0335","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.ctrv.2016.10.002","article-title":"Stereotactic ablative radiotherapy for early stage non-small cell lung cancer: A critical literature review of predictive factors of relapse","volume":"50","author":"Loganadane","year":"2016","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.canrad.2020.04.009_bib0340","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.jtho.2016.11.002","article-title":"A histologic basis for the efficacy of SBRT to the lung","volume":"12","author":"Woody","year":"2017","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.canrad.2020.04.009_bib0345","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1007\/s00066-018-1335-x","article-title":"Prognostic factors in stereotactic body radiotherapy of lung metastases","volume":"194","author":"Borm","year":"2018","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.canrad.2020.04.009_bib0350","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.canrad.2020.04.009_bib0355","doi-asserted-by":"crossref","first-page":"20160113","DOI":"10.1259\/bjr.20160113","article-title":"Pulmonary imaging after stereotactic radiotherapy\u2014does RECIST still apply?","volume":"89","author":"Mattonen","year":"2016","journal-title":"Br J Radiol"},{"key":"10.1016\/j.canrad.2020.04.009_bib0360","doi-asserted-by":"crossref","first-page":"033502","DOI":"10.1118\/1.4866219","article-title":"Early prediction of tumor recurrence based on CT texture changes after stereotactic ablative radiotherapy (SABR) for lung cancer","volume":"41","author":"Mattonen","year":"2014","journal-title":"Med Phys"},{"key":"10.1016\/j.canrad.2020.04.009_bib0365","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.radonc.2013.06.047","article-title":"features for detection of local recurrence after stereotactic ablative radiotherapy for lung cancer","volume":"109","author":"Huang","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2020.04.009_bib0370","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ijrobp.2016.04.003","article-title":"Validation of high-risk computed tomography features for detection of local recurrence after stereotactic body radiation therapy for early-stage non-small cell lung cancer","volume":"96","author":"Peulen","year":"2016","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.canrad.2020.04.009_bib0375","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.lungcan.2006.12.009","article-title":"FDG-PET and stereotactic body radiotherapy (SBRT) for stage I non-small-cell lung cancer","volume":"56","author":"Hoopes","year":"2007","journal-title":"Lung Cancer"},{"key":"10.1016\/j.canrad.2020.04.009_bib0380","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.radonc.2010.04.011","article-title":"Characterization of FDG-PET images after stereotactic body radiation therapy for lung cancer","volume":"97","author":"Matsuo","year":"2010","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2020.04.009_bib0385","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/BF02985960","article-title":"(18F)-FDG and (11C)-methionine PET for evaluation of treatment response of lung cancer after stereotactic radiotherapy","volume":"18","author":"Ishimori","year":"2004","journal-title":"Ann Nucl Med"},{"key":"10.1016\/j.canrad.2020.04.009_bib0390","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1756-8722-3-6","article-title":"CyberKnife radiosurgery for inoperable stage IA non-small cell lung cancer: (18F)-fluorodeoxyglucose positron emission tomography\/computed tomography serial tumor response assessment","volume":"3","author":"Vahdat","year":"2010","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.canrad.2020.04.009_bib0395","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ijrobp.2017.09.035","article-title":"Incidence of high-risk radiologic features in patients without local recurrence after stereotactic ablative radiation therapy for early-stage non-small cell lung cancer","volume":"100","author":"Ronden","year":"2018","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.canrad.2020.04.009_bib0400","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ejrad.2017.04.022","article-title":"Assessment of treatment response after lung stereotactic body radiotherapy using diffusion weighted magnetic resonance imaging and positron emission tomography: a pilot study","volume":"92","author":"Shintani","year":"2017","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.canrad.2020.04.009_bib0405","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1148\/radiol.14122524","article-title":"State of the art: Response assessment in lung cancer in the era of genomic medicine","volume":"271","author":"Nishino","year":"2014","journal-title":"Radiology"},{"key":"10.1016\/j.canrad.2020.04.009_bib0410","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1109\/MSP.2019.2900993","article-title":"From handcrafted to deep-learning-based cancer radiomics: challenges and opportunities","volume":"36","author":"Afshar","year":"2019","journal-title":"IEEE Signal Process Mag"},{"key":"10.1016\/j.canrad.2020.04.009_bib0415","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1007\/s00066-019-01452-7","article-title":"Radiomic analysis of planning computed tomograms for predicting radiation-induced lung injury and outcome in lung cancer patients treated with robotic stereotactic body radiation therapy","volume":"195","author":"Bousabarah","year":"2019","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.canrad.2020.04.009_bib0420","doi-asserted-by":"crossref","first-page":"20180228","DOI":"10.1259\/bjr.20180228","article-title":"The use of texture-based radiomics CT analysis to predict outcomes in early-stage non-small cell lung cancer treated with stereotactic ablative radiotherapy","volume":"92","author":"Starkov","year":"2019","journal-title":"Br J Radiol"},{"key":"10.1016\/j.canrad.2020.04.009_bib0425","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.radonc.2016.05.024","article-title":"CT-based radiomic analysis of stereotactic body radiation therapy patients with lung cancer","volume":"120","author":"Huynh","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2020.04.009_bib0430","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.radonc.2018.06.025","article-title":"Unsupervised machine learning of radiomic features for predicting treatment response and overall survival of early stage non-small cell lung cancer patients treated with stereotactic body radiation therapy","volume":"129","author":"Li","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2020.04.009_bib0435","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.1016\/S0167-8140(16)33523-X","article-title":"124: Detection of local cancer recurrence after stereotactic ablative radiotherapy (SABR) for Lung cancer: physician performance versus radiomic assessment","volume":"120","author":"Mattonen","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2020.04.009_bib0440","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/1748-717X-7-123","article-title":"Organizing pneumonia after stereotactic ablative radiotherapy of the lung","volume":"7","author":"Murai","year":"2012","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.canrad.2020.04.009_bib0445","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1093\/jrr\/rrv049","article-title":"Radiation-induced organizing pneumonia after stereotactic body radiotherapy for lung tumor","volume":"56","author":"Ochiai","year":"2015","journal-title":"J Radiat Res (Tokyo)"},{"key":"10.1016\/j.canrad.2020.04.009_bib0450","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1097\/JTO.0000000000000453","article-title":"Stereotactic ablative radiotherapy for centrally located early stage non\u2013small-cell lung cancer: what we have learned","volume":"10","author":"Chang","year":"2015","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.canrad.2020.04.009_bib0455","doi-asserted-by":"crossref","first-page":"981","DOI":"10.3390\/cancers7020820","article-title":"Complications from stereotactic body radiotherapy for lung cancer","volume":"7","author":"Kang","year":"2015","journal-title":"Cancers"},{"key":"10.1016\/j.canrad.2020.04.009_bib0460","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/1471-2407-13-68","article-title":"Rib fracture after stereotactic radiotherapy for primary lung cancer: prevalence, degree of clinical symptoms, and risk factors","volume":"13","author":"Nambu","year":"2013","journal-title":"BMC Cancer"},{"key":"10.1016\/j.canrad.2020.04.009_bib0465","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s13014-015-0406-8","article-title":"Radiation-induced rib fracture after stereotactic body radiotherapy with a total dose of 54-56Gy given in 9-7 fractions for patients with peripheral lung tumor: impact of maximum dose and fraction size","volume":"10","author":"Aoki","year":"2015","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.canrad.2020.04.009_bib0470","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1097\/JTO.0000000000000435","article-title":"Follow-up of patients after stereotactic radiation for lung cancer: a primer for the nonradiation oncologist","volume":"10","author":"Huang","year":"2015","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.canrad.2020.04.009_bib0475","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jtcvs.2012.05.060","article-title":"The American Association for Thoracic Surgery guidelines for lung cancer screening using low-dose computed tomography scans for lung cancer survivors and other high-risk groups","volume":"144","author":"Jaklitsch","year":"2012","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.canrad.2020.04.009_bib0480","unstructured":"NCCN clinical practice guidelines in oncology - non-small cell lung cancer n.d. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/nscl.pdf. (accessed October 19, 2019)."}],"container-title":["Cancer\/Radioth\u00e9rapie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321820301244?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321820301244?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T12:32:48Z","timestamp":1761136368000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1278321820301244"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":48,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S1278321820301244"],"URL":"https:\/\/doi.org\/10.1016\/j.canrad.2020.04.009","relation":{},"ISSN":["1278-3218"],"issn-type":[{"value":"1278-3218","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Radiological assessment after stereotactic body radiation of lung tumours","name":"articletitle","label":"Article Title"},{"value":"Cancer\/Radioth\u00e9rapie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canrad.2020.04.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Soci\u00e9t\u00e9 fran\u00e7aise de radioth\u00e9rapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}